Immunotherapy First for BRAF Melanoma Edges Out Targeted Combination
(MedPage Today) -- First-line immunotherapy for BRAF-positive melanoma, followed by targeted therapy at progression, led to a "clinically meaningful" survival benefit, a randomized trial showed.
Combination immunotherapy with nivolumab (Opdivo... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 29, 2022 Category: Dermatology Source Type: news
Make the Diagnosis: His Skin is Slacking Off
(MedPage Today) -- (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 28, 2022 Category: Dermatology Source Type: news
What Caused This Rapidly Enlarging Facial Abscess?
(MedPage Today) -- Expansion over several weeks necessitated timely diagnosis and ruling out mimicking conditions (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 14, 2022 Category: Dermatology Source Type: news
Neoadjuvant Cemiplimab Active in Resectable Cutaneous Squamous Cell Carcinoma
(MedPage Today) -- PARIS -- Neoadjuvant therapy with cemiplimab (Libtayo) achieved deep pathologic responses in patients with resectable cutaneous squamous cell carcinoma (cSCC), according to research presented here.
Among 79 patients treated... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 13, 2022 Category: Dermatology Source Type: news
Tumor Infiltrating Lymphocytes Reemerge as Potential Melanoma Option
(MedPage Today) -- PARIS -- More than twice as many patients with previously treated advanced melanoma remained progression-free at 6 months when they received their own tumor infiltrating lymphocytes (TILs) instead of immunotherapy, a randomized... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 12, 2022 Category: Dermatology Source Type: news
Inflammation Marker May Spot Atopic Dermatitis Risk Early in Childhood
(MedPage Today) -- Elevated levels of an inflammation marker in the skin during infancy doubled the likelihood that a child would develop atopic dermatitis by age 2 years, a prospective study in newborns showed.
The hazard ratio (HR) for atopic... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 7, 2022 Category: Dermatology Source Type: news
Keytruda Plus T-VEC Falls Short in Unresectable Melanoma
(MedPage Today) -- Pembrolizumab (Keytruda) plus intratumoral talimogene laherparepvec (T-VEC, Imlygic) did not significantly improve survival in unresectable melanoma as compared with pembrolizumab alone, an international phase III trial showed... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 3, 2022 Category: Dermatology Source Type: news
Make the Diagnosis: Don ’t Lose Time Making This Diagnosis
(MedPage Today) -- (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 24, 2022 Category: Dermatology Source Type: news
Can COVID-19 Cause Hair Loss?
(MedPage Today) -- Clinicians are seeing an influx of patients who have an unsettling side effect after COVID: losing their hair.
Brian Abittan, MD, the director of skin and hair rejuvenation at Mount Sinai Health System in New York, said that... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 12, 2022 Category: Dermatology Source Type: news
Make the Diagnosis: Her Symptoms Are Bugging Her
(MedPage Today) -- (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 11, 2022 Category: Dermatology Source Type: news
Study: Flares in Pustular Psoriasis Often Undertreated
(MedPage Today) -- Many patients with generalized pustular psoriasis (GPP) flares got no specific treatment for them, despite their high risk of severe complications, according to the biggest study of these episodes to date.
Among 1,535 patients... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 10, 2022 Category: Dermatology Source Type: news
Asian Psoriasis Patients Get Less Time With Dermatologists, Study Suggests
(MedPage Today) -- Asian patients with psoriasis receive less face-to-face time with dermatologists, according to a cross-sectional study.
Among over 4 million patient visits for psoriasis, mean duration of visit was 9.2 minutes for Asian patients... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 3, 2022 Category: Dermatology Source Type: news
Sentinel Lymph Node Biopsy Can Be Therapeutic in Melanoma Patients
(MedPage Today) -- Sentinel lymph node (SLN) biopsy without completion lymph node dissection (CLND) led to regional nodal disease control in melanoma patients, even those with risk factors for in-basin recurrence, according to an analysis of a... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 3, 2022 Category: Dermatology Source Type: news
What Caused Man's Saddle-Nose Deformity Years After Lymphoma Dx?
(MedPage Today) -- Rare diagnosis points to need for thorough workup in patients with severe nasal congestion (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 1, 2022 Category: Dermatology Source Type: news
Durable Responses, Safety in Atopic Dermatitis Treated With IL-13 Inhibitor
(MedPage Today) -- The interleukin (IL)-13 inhibitor tralokinumab (Adbry) for atopic dermatitis provided long-term disease control with a favorable safety profile and improved quality of life (QoL), data from two studies showed.
Interim results... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - July 28, 2022 Category: Dermatology Source Type: news
